US FDA approves Boston Scientific's drug-coated heart device

The approval makes the device, branded Agent, the first drug-coated balloon catheter in the U.S. to treat coronary in-stent restenosis (ISR) in patients with a type of heart disease. ISR involves accumulation of plaque or scar tissue under the stent, causing a previously opened heart vessel to narrow again.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/mQSt4Oi
via